| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12640-018-9896-0 |
| P698 | PubMed publication ID | 29611150 |
| P50 | author | Mariza Bortolanza | Q56285558 |
| Elaine Del-Bel | Q69362909 | ||
| Glauce Nascimento | Q88251167 | ||
| P2093 | author name string | C R A Leite-Panissi | |
| G C Nascimento | |||
| K Bariotto-Dos-Santos | |||
| P2860 | cites work | Pain in Parkinson disease: a review of the literature | Q27011913 |
| L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function | Q30837835 | ||
| Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease. | Q31039577 | ||
| Neurophysiologic study of central pain in patients with Parkinson disease | Q33308473 | ||
| Pain perception in acute model mice of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Q35664615 | ||
| Pain and motor complications in Parkinson's disease | Q36226497 | ||
| Levodopa raises objective pain threshold in Parkinson's disease: a RIII reflex study | Q36226722 | ||
| Nociceptive behavioral responses to chemical, thermal and mechanical stimulation after unilateral, intrastriatal administration of 6-hydroxydopamine | Q36791559 | ||
| Pain, affective symptoms, and cognitive deficits in patients with cerebral dopamine dysfunction | Q37276899 | ||
| Attenuation of hyperalgesia responses via the modulation of 5-hydroxytryptamine signalings in the rostral ventromedial medulla and spinal cord in a 6-hydroxydopamine-induced rat model of Parkinson's disease | Q37635829 | ||
| The striatum and pain modulation | Q37905697 | ||
| Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool | Q37974589 | ||
| Nigrostriatal dopaminergic depletion increases static orofacial allodynia | Q38539397 | ||
| Mechanisms Explaining Muscle Fatigue and Muscle Pain in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): a Review of Recent Findings. | Q39100152 | ||
| Subthalamic deep brain stimulation modulates conscious perception of sensory function in Parkinson's disease | Q39168176 | ||
| The role of the basal ganglia in nociception and pain | Q40506202 | ||
| Modulation of the inflammatory response in the rat TMJ with increasing doses of complete Freund's adjuvant | Q40681997 | ||
| Effects of electrolytic and 6-hydroxydopamine lesions of rat nigrostriatal pathway on nitric oxide synthase and nicotinamide adenine dinucleotide phosphate diaphorase | Q42453311 | ||
| A nitric oxide synthase inhibitor decreases 6-hydroxydopamine effects on tyrosine hydroxylase and neuronal nitric oxide synthase in the rat nigrostriatal pathway. | Q42525341 | ||
| L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. | Q42539090 | ||
| Nitric Oxide Synthase Inhibitor Improves De Novo and Long-Term l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats. | Q42755842 | ||
| Levodopa analgesia in experimental neuropathic pain | Q42919323 | ||
| Asymmetric pain processing in Parkinson's disease | Q44058129 | ||
| Antinociceptive mechanism of L-DOPA. | Q44994079 | ||
| Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. | Q45281153 | ||
| Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial | Q45710977 | ||
| Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease | Q46080337 | ||
| Low-frequency rTMS of the premotor cortex reduces complex movement patterns in a patient with pantothenate kinase-associated neurodegenerative disease (PKAN). | Q46096649 | ||
| Functional abdominal pain: the basic science | Q46291050 | ||
| Role for cyclooxygenase 2 in the development and maintenance of neuropathic pain and spinal glial activation | Q46727081 | ||
| Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease | Q46814956 | ||
| Behavioral responses and Fos activation following painful stimuli in a rodent model of Parkinson's disease | Q46990142 | ||
| Altered structural connectivity of pain-related brain network in burning mouth syndrome-investigation by graph analysis of probabilistic tractography | Q48237366 | ||
| Biochemical and anatomical characterization of forepaw adjusting steps in rat models of Parkinson's disease: studies on medial forebrain bundle and striatal lesions | Q48240667 | ||
| Parkinson's disease symptoms: the patient's perspective | Q48349277 | ||
| Effects of subthalamic deep brain stimulation with duloxetine on mechanical and thermal thresholds in 6OHDA lesioned rats | Q48393308 | ||
| Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. | Q48408339 | ||
| Organization of diencephalic dopamine neurones projecting to the spinal cord in the rat. | Q48453484 | ||
| Fos-like immunoreactivity induced by intraplantar injection of endotoxin and its reduction by morphine | Q48592097 | ||
| Peri-operative thoracic epidural analgesia for thoracotomy. | Q51530264 | ||
| Quantitative and fiber-selective evaluation of pain and sensory dysfunction in patients with Parkinson's disease. | Q53633040 | ||
| Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease? | Q60709045 | ||
| Pain sensitivity and descending inhibition of pain in Parkinson's disease. | Q67217423 | ||
| Effects of dopaminergic agents on carrageenan hyperalgesia in rats | Q73019282 | ||
| The involvement of dopamine in nociception: the role of D(1) and D(2) receptors in the dorsolateral striatum | Q73455049 | ||
| Pain-pressure threshold in patients with Parkinson's disease with and without dyskinesia | Q79753444 | ||
| Quantitative measurement of pain sensation in patients with Parkinson disease | Q80228520 | ||
| Temporal changes in inflammatory mediator concentrations in an adjuvant model of temporomandibular joint inflammation | Q81549044 | ||
| Development of an effective topical liposomal formulation for localized analgesia and anti-inflammatory actions in the Complete Freund's Adjuvant rodent model of acute inflammatory pain | Q86036539 | ||
| P433 | issue | 4 | |
| P921 | main subject | dyskinesia | Q629444 |
| P304 | page(s) | 799-807 | |
| P577 | publication date | 2018-04-02 | |
| P1433 | published in | Neurotoxicity Research | Q15764278 |
| P1476 | title | Nociceptive Response to L-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats | |
| P478 | volume | 34 |
Search more.